These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2663611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine.
    Mobassaleh M, Donohue-Rolfe A, Jacewicz M, Grand RJ, Keusch GT.
    J Infect Dis; 1988 May; 157(5):1023-31. PubMed ID: 3283253
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3.
    Newburg DS, Ashkenazi S, Cleary TG.
    J Infect Dis; 1992 Oct; 166(4):832-6. PubMed ID: 1527419
    [Abstract] [Full Text] [Related]

  • 5. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
    Cooling LL, Walker KE, Gille T, Koerner TA.
    Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
    [Abstract] [Full Text] [Related]

  • 6. Verotoxin receptor glycolipid in human renal tissue.
    Boyd B, Lingwood C.
    Nephron; 1989 Sep; 51(2):207-10. PubMed ID: 2644572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine.
    Mobassaleh M, Koul O, Mishra K, McCluer RH, Keusch GT.
    Am J Physiol; 1994 Oct; 267(4 Pt 1):G618-24. PubMed ID: 7943326
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
    Ashkenazi S, Cleary TG.
    J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
    Waddell T, Head S, Petric M, Cohen A, Lingwood C.
    Biochem Biophys Res Commun; 1988 Apr 29; 152(2):674-9. PubMed ID: 3284526
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides.
    Head S, Ramotar K, Lingwood C.
    Infect Immun; 1990 Jun 29; 58(6):1532-7. PubMed ID: 2160427
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    Jacewicz MS, Mobassaleh M, Gross SK, Balasubramanian KA, Daniel PF, Raghavan S, McCluer RH, Keusch GT.
    J Infect Dis; 1994 Mar 29; 169(3):538-46. PubMed ID: 8158025
    [Abstract] [Full Text] [Related]

  • 20. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
    Szymczak-Kulus K, Weidler S, Bereznicka A, Mikolajczyk K, Kaczmarek R, Bednarz B, Zhang T, Urbaniak A, Olczak M, Park EY, Majorczyk E, Kapczynska K, Lukasiewicz J, Wuhrer M, Unverzagt C, Czerwinski M.
    J Biol Chem; 2021 Mar 29; 296():100299. PubMed ID: 33460651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.